Annals of Oncology

News:

Asia on the move
Ann Oncol 8: 101.
[PDF] [Request Permissions]

Changes suggested in Dutch system of reporting euthanasia and assistated suicide
Ann Oncol 8: 101-102.
[PDF] [Request Permissions]

Labour vows to change the NHS
Ann Oncol 8: 102-103.
[PDF] [Request Permissions]

Awards, appointments
Ann Oncol 8: 103.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 8: 103-104.
[PDF] [Request Permissions]

Editorials:

P. A. Ganz

Sexual functioning after breast cancer: A conceptual framework for future studies
Ann Oncol 8: 105-107.
[PDF] [Request Permissions]

J. Bergh

Dose intensity in patients with metastatic breast cancer - time for novel thoughts?
Ann Oncol 8: 109-110.
[PDF] [Request Permissions]

Book reviews:

P. Boyle

Book review
Ann Oncol 8: 108.
[PDF] [Request Permissions]

J. O. Armitage

Book review
Ann Oncol 8: 206.
[PDF] [Request Permissions]

Special articles:

P. J. Ross, A. Webb, D. Cunningham, J. Prendiville, A. R. Norman, and J. Oates

Infusional 5-fluorouracil in the treatment of gastrointestinal cancers: The Royal Marsden Hospital experience
Ann Oncol 8: 111-115.
[PDF] [Request Permissions]

Review:

R. G. Simonetti, A. Liberati, C. Angiolini, and L. Pagliaro

Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials
Ann Oncol 8: 117-136.
[Abstract] [PDF] [Request Permissions]

Commentary:

S. Jones and P. Boffetta

AACR/IARC meeting on carcinogenesis from environmental pollution: Assessment of human risk and strategies for prevention: 6–9 October 1996, Budapest, Hungary
Ann Oncol 8: 137-138.
[PDF] [Request Permissions]

Arena: Point-counterpoint:

S. Wadler and E. L. Schwartz

Role of interferon as a modulator of fluoropyrimidines: Reply to a recent editorial
Ann Oncol 8: 139-140.
[PDF] [Request Permissions]

Reply from the author:

Reply from the author
Ann Oncol 8: 141.
[PDF] [Request Permissions]

Rapid publication:

V. Diehl, M. Sieber, U. Rüffer, B. Lathan, D. Hasenclever, M. Pfreundschuh, M. Loeffler, D. Lieberz, P. Koch, M. Adler, H. Tesch, and for the German Hodgkin's Lymphoma Study Group

BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease
Ann Oncol 8: 143-148.
[Abstract] [PDF] [Request Permissions]

Original articles:

S. Barni and R. Mondin

Sexual dysfunction in treated breast cancer patients
Ann Oncol 8: 149-153.
[Abstract] [PDF] [Request Permissions]

G. Brufman, E. Colajori, N. Ghilezan, M. Lassus, M. Martoni, N. Perevodchikova, C. Tosello, D. Viaro, C. Zielinski, and the Epirubicin High Dose (HEPI 010) Study Group

Doubling epirubicin dose intensity (100 mg/m² versus 50 mg/m²) in the FEC regimen significantly increases response rates. An international randomised phase III study in metastatic breast cancer
Ann Oncol 8: 155-162.
[Abstract] [PDF] [Request Permissions]

B. Glimelius, K. Ekström, K. Hoffman, W. Graf, P.-O. Sjödén, U. Haglund, C. Svensson, L.-K. Enander, T. Linné, H. Sellsröm, and R. Heuman

Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer
Ann Oncol 8: 163-168.
[Abstract] [PDF] [Request Permissions]

R. Labianca, S. Cascinu, L. Frontini, S. Barni, G. Fiorentini, G. Comella, A. Zaniboni, O. Gottardi, E. Arnoldi, C. Oliani, M. Duro, G. Pavanato, G. Martignoni, A. Raina, E. Piazza, G. Dallavalle, R. Valsecchi, G. Pancera, and G. Luporini on behalf of GISCAD (Italian Group for the Study of Digestive Tract Cancer)

High- versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: A ‘GISCAD’ phase III study
Ann Oncol 8: 169-174.
[Abstract] [PDF] [Request Permissions]

E. Montefusco, M. C. Petti, G. Alimena, R. Latagliata, F. Celesti, S. Capria, S. Amadori, G. Avvisati, and F. Mandelli

Etoposide, intermediate-dose cytarabine and carboplatin (VAC): A combination therapy for the blastic phase of chronic myelogenous leukemia
Ann Oncol 8: 175-179.
[Abstract] [PDF] [Request Permissions]

J. L. Pater, W. S. Lofters, B. Zee, E. Dempsey, D. Walde, J.-P. Moquin, K. Wilson, P. Hoskins, R. M. Guevin, S. Verma, R. Navari, J. E. Krook, J. Hainsworth, M. Palmer, and C. Chin

The role of the 5-HT₃ antagonists ondansetron and dolasetron in the control of delayed onset nausea and vomiting in patients receiving moderately emetogenic chemotherapy
Ann Oncol 8: 181-185.
[Abstract] [PDF] [Request Permissions]

P. H. E. Hilkens, J. Verweij, Ch. J. Vecht, G. Stoter, and M. J. van den Bent

Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere)
Ann Oncol 8: 187-190.
[Abstract] [PDF] [Request Permissions]

Clinical case:

M. Merad, A. Le Cesne, P. Baldeyrou, B. Mesurolle, and T. Le Chevailer

Docetaxel and interstitial pulmonary injury
Ann Oncol 8: 191-194.
[PDF] [Request Permissions]

Short reports:

M. A. Dimopoulos, C. Papadimitriou, C. Gennatas, T. Akrivos, G. Vlahos, Z. Voulgaris, E. Diacomanolis, P. Athanassiades, and S. Mihalas

Ifosfamide and paclitaxel salvage chemotherapy for advanced epithelial ovarian cancer
Ann Oncol 8: 195-197.
[Abstract] [PDF] [Request Permissions]

H. Rashid, J. D. Long, and R. G. Wadleigh

Management of secretions in esophageal cancer patients with glycopyrrolate
Ann Oncol 8: 198-199.
[Abstract] [PDF] [Request Permissions]

J. A. Burger, A. Ochs, K. Wirth, D. P. Berger, R. Mertelsmann, R. Engelhardt, M. Roessle, and K. Haag

The transjugular stent implantation for the treatment of malignant portal and hepatic vein obstruction in cancer patients
Ann Oncol 8: 200-202.
[Abstract] [PDF] [Request Permissions]

Letters to the editor:

H. K. van Halteren, J. J. Keuning, and G. Vreugdenhil

5-Fluorouracil-based treatment of patients with advanced colorectal carcinoma outside clinical trials: Importance of limited toxicity
Ann Oncol 8: 203.
[PDF] [Request Permissions]

C. A. Presant, W. Wolf, and V. Waluch

5-Fluorouracil revisited: A new perspective for treatment planning
Ann Oncol 8: 203-204.
[PDF] [Request Permissions]

Letters:

J. Baumgart and H. J. Kühnel

L-asparagine-depletion: Another opinion
Ann Oncol 8: 204.
[PDF] [Request Permissions]

C. Rizzari, V. Conter, M. D'Incalci, and G. Masera

This letter was referred to the authors, who respond as follows:
Ann Oncol 8: 205.
[PDF] [Request Permissions]

Corrigendum:

T. Colombo, O. Gonzalez, M. Zucchetti, M. Maneo, C. Sessa, A. Goldhirsch, and M. D'Incalci

Corrigendum
Ann Oncol 8: 207.
[Abstract] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.